Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
Early Changes in Lymphocyte/Monocyte Ratio on Treatment as a Prognostic Marker to Predict Overall Survival in Patients with Advanced Cancer Treated with Immune Checkpoint Inhibitors.
Journal: Cancer investigation
Published: October 10, 2025
Impact of immune-related and non-immune related hospital admissions on survival of patients with non-small cell lung cancer receiving first-line immunotherapy.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: August 07, 2025
Phase 1 dose escalation trial of the selective adenosine A2B antagonist PBF-1129 in patients with metastatic non-small cell lung cancer.
Journal: Investigational new drugs
Published: July 22, 2025
Response to Dabrafenib Plus Trametinib in a Patient With an Uncommon Activating BRAF Mutation: A First in Non-Small Cell Lung Cancer.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: October 03, 2023
A Phase 2 Trial of Primary Tumor Stereotactic Body Radiation Therapy Boost Before Concurrent Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer.
Journal: International journal of radiation oncology, biology, physics
Published: August 30, 2023
Improving Access to Early Palliative Care Delivery for Patients With an Advanced Thoracic Malignancy Through an Embedded Oncopalliative Clinic Model.
Journal: JCO oncology practice
Published: June 06, 2023
A single-arm, multicenter, phase II trial of osimertinib in patients with epidermal growth factor receptor exon 18 G719X, exon 20 S768I, or exon 21 L861Q mutations.
Journal: ESMO open
Published: December 07, 2022
Feasibility of an embedded palliative care clinic model for patients with an advanced thoracic malignancy.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: October 28, 2022
Mean platelet volume, thrombocytosis, and survival in non-small cell lung cancer patients treated with first-line pembrolizumab alone or with chemotherapy.
Journal: Cancer immunology, immunotherapy : CII
Published: September 02, 2022
Immune checkpoint inhibitor-induced hepatitis injury: risk factors, outcomes, and impact on survival.
Journal: Journal of cancer research and clinical oncology
Published: May 31, 2022
Impact of an Embedded Palliative Care Clinic on Healthcare Utilization for Patients With a New Thoracic Malignancy.
Journal: Frontiers in oncology
Published: December 15, 2021
Short communication: The activity of brigatinib in patients with disease progression after next generation anaplastic lymphoma tyrosine kinase inhibitors and an exploratory analysis of circulating tumor DNA.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: November 11, 2021
Last Updated: 09/26/2026